Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by alveolar epithelial cell injury and lung fibroblast overactivation. At present, only two drugs are approved by the FDA for the treatment of IPF, including the synthetic pyridinone drug, pirfenido...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Yang, Wang, Yanhua, Bi, Zhun, Huang, Kai, Gao, Jingjing, Li, Xiaohe, Li, Shimeng, Wei, Luqing, Zhou, Honggang, Yang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031887/
https://www.ncbi.nlm.nih.gov/pubmed/36949426
http://dx.doi.org/10.1186/s12890-023-02385-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031887/
https://www.ncbi.nlm.nih.gov/pubmed/36949426
http://dx.doi.org/10.1186/s12890-023-02385-9

Ejemplares similares